Sleeping pills MGP4

Speech on Sleeping Pills

    


       Does anyone have trouble sleeping? Has anyone here ever experimented with sleeping pills? Actually, some people have trouble sleeping, so doctors have prescribed people sleeping pills to try to help them sleep better at night. For a really long time Ambien has been a life saver for people with sleeping problems. Now there are some new kinds of sleeping pills that are about to hit the market that don’t cause morning after hangovers and are less addictive. In April of 2005, the researchers from University of Memphis medical center introduced a drug called Lunesta. It was the first drug approved with no limit on refills. Late Friday, the Food and Drug Administration approved a second drug called Rozerem. Rozerem works differently than other drugs. Rozerem binds to melatonin receptors that regulate sleep-wake cycles. The medicine makes it okay to take the drug at night with less of a chance of next-day grogginess. It is also the first prescription sleep aid to show no signs of addiction. Addiction is usually is a common side effect of sleep aids. Pfizer and Neurocrine Biosciences also have a drug, indoplin, waiting for approval from the FDA that works like Lunesta. These types of drugs are being made every day because about 60 million Americans experience insomnia annually. More and more people are turning to these drugs for sleep assistance. More than 35 million prescriptions were written for sleeping pills in the United States in 2005, which adds up to more than $2.1 million. There are other treatments for sleeping problems, such as cognitive behavior therapy, but drug makers are betting millions that Americans are choosing drugs over any other alternative. If you’re having trouble sleeping, explore all your options. Be sure to research your drug of choice. Every drug you take can affect your health, so choose wisely. 


Works Cited
Barrett, Jennifer. "Sleeping Pills: The Next Generation." Newsweek 1 Aug. 2005: 48. Opposing
            Viewpoints in Context. Web. 8 Apr. 2014.

No comments:

Post a Comment